Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Yesterday, shares of small-cap biotech Greenwich LifeSciences (NASDAQ: GLSI) surged by nearly 3,000% to an all-time high of $158.07. Today, shares are priced at $90.57, representing stock price growth of 1,650% in two days. The wild trading followed the announcement of positive clinical results for its sole immunotherapy candidate, GP2. Immunotherapies treat cancer by boosting the body's own immune system to fight it.
Are investors buying into irrational exuberance? Or did Greenwich find an effective treatment that can stop the recurrence of breast cancer? Let's find out.
Image source: Getty Images.
Source Fool.com
